Literature DB >> 19012527

Hemoglobin A1c determination in the A1C-Derived Average Glucose (ADAG) study.

Erna Lenters-Westra1, Robbert J Slingerland.   

Abstract

BACKGROUND: The A1C-Derived Average Glucose (ADAG) study was commenced to gain a better understanding of the relationship between HbA1c and average blood glucose and to investigate if HbA1c could be expressed in the same units as day-to-day glucose monitoring. Owing to the impact of the outcome of this study it was very important to determine HbA1c values with a minimum of uncertainty and as close as possible to the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) primary reference method, which is the only valid anchor of HbA1c standardization.
METHODS: Approximately 2300 samples were analyzed with four IFCC secondary reference methods. Additional off-line calibration with IFCC secondary reference material with assigned IFCC values was performed to improve the uncertainty in the HbA1c value determination.
RESULTS: Additional off-line calibration improved the 95% confidence interval between the four different HbA1c methods at HbA1c of 6.00% from +/-0.28% (5.72%-6.28%) to +/-0.20% (5.80%-6.20%) and at HbA(1c) of 9.00% from +/-0.43% (8.57%-9.43%) to +/-0.24% (8.76%-9.24%).
CONCLUSIONS: The HbA1c results used in the ADAG study were determined with the lowest uncertainty technically feasible by using four certified IFCC secondary reference methods and additional off-line calibration with IFCC secondary reference material.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012527     DOI: 10.1515/CCLM.2008.322

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  The implementation of international standardization of glycated hemoglobin. A "red-letter-day" for glycated hemoglobin in Italy: 1/1/11. Italian Recommendations of GLAD Working Group (A1c delegates WG).

Authors:  A Mosca; D Iafusco; F Meschi; M T Branca; M Carta; M L Genna; C B Giorda; R Ghidelli; G Ghislandi; A Lapolla; V Buondonno Lombardi; C A Lovagnini; M Marra; G Medea; A Pizzini; F Rossi; R Scalpone; G Tofini; M Trovati; M Zaninotto
Journal:  J Endocrinol Invest       Date:  2011-05-31       Impact factor: 4.256

Review 2.  Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.

Authors:  Ebenezer A Nyenwe; Terri W Jerkins; Guillermo E Umpierrez; Abbas E Kitabchi
Journal:  Metabolism       Date:  2011-01       Impact factor: 8.694

Review 3.  Implications of using hemoglobin A1C for diagnosing diabetes mellitus.

Authors:  Samir Malkani; John P Mordes
Journal:  Am J Med       Date:  2011-05       Impact factor: 4.965

4.  Intermittent high glucose promotes expression of proinflammatory cytokines in monocytes.

Authors:  Yang Li-Bo; Qi Wen-Bo; Lv Xiao-Hong; Feng You-Lun; Zhang Tie
Journal:  Inflamm Res       Date:  2010-11-10       Impact factor: 4.575

5.  A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19).

Authors:  Kornelis J J van Hateren; Iefke Drion; Nanne Kleefstra; Klaas H Groenier; Sebastiaan T Houweling; Klaas van der Meer; Henk J G Bilo
Journal:  BMJ Open       Date:  2012-08-29       Impact factor: 2.692

6.  The Multimorbidity Index: A Tool for Assessing the Prognosis of Patients from Their History of Illness.

Authors:  Farrokh Alemi; Cari R Levy; Raya E Kheirbek
Journal:  EGEMS (Wash DC)       Date:  2016-10-13

7.  Time in Range: How to Measure It, How to Report It, and Its Practical Application in Clinical Decision-Making.

Authors:  Eugene E Wright; Kayla Morgan; Danny K Fu; Nick Wilkins; William J Guffey
Journal:  Clin Diabetes       Date:  2020-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.